These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27246292)

  • 1. Selective sentinel node biopsy after intratumour administration of radiotracer in breast cancer patients treated with neoadjuvant chemotherapy in relation to the level of tumour response.
    Díaz-Expósito R; Martí-Bonmatí L; Burgués O; Casáns-Tormo I; Bermejo-de Las Heras B; Julve-Parreño A; Caballero-Garate A
    Rev Esp Med Nucl Imagen Mol; 2016; 35(6):358-364. PubMed ID: 27246292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Axillary pathologic response after neoadjuvant chemotherapy in locally advanced breast cancer with axillary involvement].
    Jiménez-Ballvé A; Serrano-Palacio A; García-Sáenz JA; Ortega Candil A; Salsidua-Arroyo O; Román-Santamaría JM; Pelayo Alarcón A; Fuentes Ferrer ME; Carreras-Delgado JL
    Rev Esp Med Nucl Imagen Mol; 2015; 34(4):230-5. PubMed ID: 25743035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Selective biopsy of the sentinel lymph node in patients with breast cancer and previous excisional biopsy: is there a change in the reliability of the technique according to time from surgery?].
    Sabaté-Llobera A; Notta PC; Benítez-Segura A; López-Ojeda A; Pernas-Simon S; Boya-Román MP; Bajén MT
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):9-12. PubMed ID: 25455507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of sentinel lymph node biopsy in breast cancer women N1-N2 with complete axillary response after neoadjuvant chemotherapy. Multicentre study in Tarragona.
    Carrera D; de la Flor M; Galera J; Amillano K; Gomez M; Izquierdo V; Aguilar E; López S; Martínez M; Martínez S; Serra JM; Pérez M; Martin L
    Rev Esp Med Nucl Imagen Mol; 2016; 35(4):221-5. PubMed ID: 26848141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of previous breast surgery in sentinel lymph node biopsy in patients with breast cancer.
    López-Prior V; Díaz-Expósito R; Casáns Tormo I
    Rev Esp Med Nucl Imagen Mol; 2017; 36(4):212-218. PubMed ID: 28359747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients.
    Maza S; Thomas A; Winzer KJ; Hüttner C; Blohmer JU; Hauschild M; Richter M; Krössin T; Geworski L; Zander A; Guski H; Munz DL
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):671-5. PubMed ID: 14745517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation.
    Feggi L; Basaglia E; Corcione S; Querzoli P; Soliani G; Ascanelli S; Prandini N; Bergossi L; Carcoforo P
    Eur J Nucl Med; 2001 Nov; 28(11):1589-96. PubMed ID: 11702098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.
    Rebollo-Aguirre AC; Gallego-Peinado M; Menjón-Beltrán S; García-García J; Pastor-Pons E; Chamorro-Santos CE; Ramos-Font C; Salamanca-Ballesteros A; Llamas-Elvira JM; Olea-Serrano N
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison between intratumoral and peritumoral injection of radiotracer for locating and biopsying the sentinel lymph node in nonpalpable breast cancer].
    Mariscal A; Balliu E; Solá M; Pérez de Tudela A; Fraile M; Julián JF
    Radiologia; 2008; 50(4):309-16. PubMed ID: 18783652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme.
    Fernández A; Cortés M; Benito E; Azpeitia D; Prieto L; Moreno A; Ricart Y; Mora J; Escobedo A; Martín Comín J
    Nucl Med Commun; 2001 Apr; 22(4):361-6. PubMed ID: 11338045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer. Its relation with molecular subtypes].
    Ruano R; Ramos M; García-Talavera JR; Ramos T; Rosero AS; González-Orus JM; Sancho M
    Rev Esp Med Nucl Imagen Mol; 2014; 33(6):340-5. PubMed ID: 24856234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritumoural versus subareolar administration of technetium-99m nanocolloid for sentinel lymph node detection in breast cancer: preliminary results of a prospective intra-individual comparative study.
    Maza S; Valencia R; Geworski L; Zander A; Guski H; Winzer KJ; Munz DL
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):651-6. PubMed ID: 12612811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The feasibility and the role of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
    Péley G; Török K; Farkas E; Mátrai Z; Horváth Z; Sinkovics I; Hitre E; Rényi-Vámos F; Orosz Z; Köves I
    Magy Onkol; 2006; 50(1):19-23. PubMed ID: 16617379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node biopsy in N+ breast cancer with conversion into N0 after neoadjuvant chemotherapy.
    Tamayo Carabaño D; Álvarez Pérez R; De Bonilla Damiá Á; Acevedo Bañez I; Pachón Garrudo VM; Jiménez-Hoyuela García JM
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(3):140-146. PubMed ID: 30594445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subareolar subcutaneous injection of blue dye versus peritumoral injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients.
    Reitsamer R; Peintinger F; Rettenbacher L; Prokop E; Sedlmayer F
    World J Surg; 2003 Dec; 27(12):1291-4. PubMed ID: 14574485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoscintigraphy in breast cancer patients after neoadjuvant chemotherapy. Diagnostic value and the work-up of sentinel node negative patients.
    Dalus K; Reitsamer R; Holzmannhofer J; Rendl G; Pirich C; Kronberger C; Rettenbacher L
    Nuklearmedizin; 2011; 50(1):33-8. PubMed ID: 21336417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intratumoral versus subareolar injection in breast cancer sentinel lymph node biopsy. A case report].
    Lanchas Alfonso I; Miguel Martínez MB; CuezvaGuzmán JF; Rupérez Arribas P; Martínez Blanco S; Yartu San Millán JM; Duque Gallo JJ
    Rev Esp Med Nucl; 2011; 30(3):171-3. PubMed ID: 21342723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer: results of the GEICAM 2005-07 study.
    Piñero-Madrona A; Escudero-Barea MJ; Fernández-Robayna F; Alberro-Adúriz JA; García-Fernández A; Vicente-García F; Dueñas-Rodriguez B; Lorenzo-Campos M; Caparrós X; Cansado-Martínez MP; Ramos-Boyero M; Rojo-Blanco R; Serra-Genís C
    Cir Esp; 2015 Jan; 93(1):23-9. PubMed ID: 24560631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Feasibility of sentinel lymph node biopsy peri-neoadjuvant chemotherapy in breast cancer].
    Zhao J; Song ZW; Huang Y; Hao XP; Liang F; Wang SB; Jin SJ; Yu CZ
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(36):2538-41. PubMed ID: 23158793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sentinel lymph node biopsy in breast cancer. Experience of the Rome Breast Cancer Study Group].
    Fortunato L; Drago S; Vitelli CE; Santoni M; Gucciardo G; Cabassi A; Farina M; La Pinta M; Remedi M; Pagano G; Silipod T; Terribile D; Stagnitto D; Grassi GB;
    Chir Ital; 2006; 58(6):689-96. PubMed ID: 17190273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.